Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis

Circulation Research

Volumn 81, Issue 4, 1997, Pages 591-599

  Bennett, Martin R ^a   Littlewood, Trevor D ^b   Schwartz, Stephen M ^c   Weissberg, Peter L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cell cycle; P53; Restenosis

Indexed keywords

DNA; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DIAGNOSIS; DNA DAMAGE; ETIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE;

EID: 0030879522     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.591     Document Type: Article

References (53)

1. Bochatonpiallat M, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1945;146:1059-1064.
2. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
3. Isner J, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
4. Han D, Haudenschild C, Hong M, Tinkle B, Leon M, Liau G. Evidence for apoptosis in human atherosclerosis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
5. Geng Y, Libby P. Evidence for apoptosis in advanced human atheronia: colocalization with interleukin-1βconverting enzyme. Am J Pathol. 1995;147:251-266.
6. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
7. Bennett MR, Evan GI, Newby AC. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994; 74:525-536.
8. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995;77:266-273.
9. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
10. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res. 1993;73: 223-231.
11. Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA bindinn. Mol Cell Biol. 1992;12:5581-5592.
12. Gottlieb E, Haffner R, von Rüden RT, Wagner EF, Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 1994;13:1368-1374.
13. Bowman T, Symonds H, Gu L, Yin C, Oren M, Van Dyke T. Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev. 1996;10:826-835.
14. Morgenstern J, Land H. Choice and manipulation of retroviral vectors. In: Murray EJ, eds. Gene Transfer and Expression Protocols. Clifton, NJ: The Humana Press Inc; 1991:181-206.
15. Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI. c-myc protein expression in untransformed fibroblasts. Oncogene. 1991;6:797-805.
16. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science. 1991;252:1708-1711.
17. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. New York, NY: Cold Spring Harbor Laboratory Press; 1989.
18. Littlewood T, Hancock D, Danielian P, Parker M, Evan G. A modified estrogen-receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995;23:1686-1690.
19. Danielian PS, White R, Hoare SA, Fawell SE, Parker MG. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and 4-hydroxylamoxifen. Mol Endocrinol. 1993;7:232-240.
20. Fan S, el Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJJ, Magrath I, Kohn KW, O'Connor PM. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 1994;54:5824-5830.
21. Malcomson R, Oren M, Wyllie A, Harrison D. p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer. 1995;72:952-957.
22. Crook T, Tidy JA, Vousden KH. Degradation of p53 cart be targeted by HPV E6 sequences distinct from those required for p53 binding and trails-activation. Cell. 1991;67:547-556.
23. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 1992;11:3045-3052.
24. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by imerleukin-6. Nature, 1991;352:345-347.
25. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A. 1992;89:4495-4499.
26. Chen YM, Chen PL, Arnaiz N, Goodrich D, Lee WH. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene 1991;6:1799-1805.
27. Baker SJ, Markowitz, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 1990;244:912-915.
28. Casey G, Lo HM, Lopez ME, Vogelstein B, Stanbridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene. 1991;6:1791-1797.
29. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CJ, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356: 215-221.
30. Iacopetta B, Wysocki S, Norman P, House A. The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol. 1995;7:399-402.
31. Slichenmeyer WJ, Nelson WG, Slebos RJ, Kastan MB. Loss of a p53-associaled G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 1993;53:4164-4168.
32. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 1994;79:329-339.
33. Gartenhaus R, Wang P, Hoffmann P. Induction of the waf1/cip1 protein and apoptosis in human T-cell leukemia-virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc Natl Acad Sci U S A. 1996; 93:265-268.
34. Levy N, Yonish RE, Oren M, Kimchi A. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Mol Cell Biol. 1493;13:7942-7952.
35. Guillouf C, Grana X, Selvakumaran M, Deluca A, Giordano A, Hoffman B, Liebermann D. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood. 1995;85:2691-2698.
36. Haupt Y, Rowan S, Shaulian E, Vousden K, Oren M. Induction of apoptosis in HELA cells by transactivation-deticient p53. Genes Dev. 1995;9:2170-2183.
37. Rowan S, Ludwig R, Haupt Y, Bates S, Lu X, Oren M, Vousden K. Specific loss of apoptotic but not cell cycle arrest function in a human tumor-derived p53 mutant. EMBO J. 1996;15:827-838.
38. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM. Fornace AJJ. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 1994;9: 3743-3751.
39. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax acne expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
40. Miyashita T, Reed J. Tumor suppressor gene p53 is a direct transcriptional activator of the human Bax gene. Cell. 1905;80:293-299.
41. Canman C, Gilmer T, Coutts S, Kastan M. Growth-factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 1995;9:600-611.
42. Oweti-Schaub L, Zhang W, Cusaek J, Angelo L, Santee S, Fujiwara T, Roth J, Deisseroth A, Zhang W, Kruzel E, Radinsky R. Wild-type human p53 and a temperature sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol. 1995;15:3032-3040.
43. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D. Immediate early up-regulation of bax expression by p53 hut not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 1994;9:1791-1798.
44. Donatella Attardi L, Lowe S, Brugarolas J, Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 1996;15:3693-3701.
45. wafl/clp1. Genes Dev. 1994;8:2817-2830.
46. Lotem J, Sachs L. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anticancer agents and viability factor deprivation in myeloid cells. Leukemia. 1995;9:685-692.
47. Knudson C, Tung K, Tourtellotte W, Brown G, Korsmeyer S. Bax-deficient mice with lymphoid hypetplasia and male germ-cell death. Science. 1995;270:96-99.
48. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMRO J. 1994;13:3286-3295.
49. Buckbinder L, Talbott R, Velascomiguel S, Takenaka I, Faha B, Seizinger B, Kley N. Induction of the growth inhibitor IGF-binding protein-3 by p53. Nature. 1995;377:646-649.
50. Werner H, Karnieli E, Rauscher F, Leroith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor-I receptor gene. Proc Natl Acad Sci U S A. 1996;93: 8318-8323.
51. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 1994;370:220-223.
52. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber D. The wt1 gene-product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 1995;9:2143-2156.
53. Polyak K, Waldman T, He T, Kinzler K, Vogelstoin B. Genetic determinants of p53-induced apoptosis and growth arrest Genes Dev. 1996;10:1945-1952.